-
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSESSING THE RELEVANCE OF HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS AND PREFERENCE-BASED MEASURES FOR UTILITY GENERATION IN EARLY HD
Mar 18, 2026, 21:38 PM -
DISMANTLING BARRIERS IN PATIENT-LED RESEARCH: UTILIZING AN AI-ENHANCED ACCESS-CENTERED RESEARCH MODEL TO EVALUATE THE INTEGRATION OF PATIENT-REPORTED OUTCOMES IN FDA ORPHAN DRUG APPROVALS
Mar 18, 2026, 21:38 PM -
AUTOMATING SYSTEMATIC LITERATURE REVIEWS (SLR) IN ONCOLOGY: DEVELOPMENT AND PERFORMANCE OF A PROPRIETARY DATA MANAGEMENT AND MAINTENANCE SYSTEM (DMS)
Mar 18, 2026, 21:38 PM -
MEDICARE COST OF MINIMALLY INVASIVE BIOMARKER TESTS TO DETECT DONOR-DERIVED CELL-FREE DNA (DD-CFDNA)
Mar 18, 2026, 21:38 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON AND COST-UTILITY OF ZORIFERTINIB VERSUS OSIMERTINIB IN TREATING NEWLY DIAGNOSED EGFR-MUTANT NSCLC WITH CNS METASTASES IN CHINA
Mar 18, 2026, 21:38 PM -
REAL-WORLD INSIGHTS INTO OBESITY PATHWAYS, PRESCRIBING, PATIENT COMPLEXITY, AND CARE GAPS THROUGH PRIMARY CARE DATABASES
Mar 18, 2026, 21:38 PM -
THE ACCESSIBILITY OF ANTI-CANCER DRUGS IN CHINA'S URBAN CUSTOMIZED COMMERCIAL MEDICAL INSURANCE
Mar 18, 2026, 21:38 PM -
EVALUATING PATIENT PREFERENCES FOR COPD MAINTENANCE TREATMENT DELIVERY DEVICES: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
VARIATION IN AVERAGE INCREMENTAL COST-EFFECTIVENESS RATIOS ACROSS DISEASE GROUPS AND THE DISTRIBUTION OF RESEARCH AND DEVELOPMENT FUNDS
Mar 18, 2026, 21:38 PM -
THE ROLE OF SOCIAL SUPPORT AND SOCIOECONOMIC STATUS ON ANNUAL GYNECOLOGIST VISIT AMONG YOUNG FEMALES
Mar 18, 2026, 21:38 PM -
TURNING DATA INTO BUSINESS MODEL INNOVATION: A PRAGMATIC CRITICAL REALIST APPROACH TO THE EUROPEAN PARADOX IN A POST-MFN WORLD
Mar 18, 2026, 21:38 PM -
POST-PANDEMIC BURDEN OF COVID-19 AMONG HIGH-RISK PATIENTS WITH ACUTE INFECTION: A CROSS-SECTIONAL SURVEY IN GERMANY
Mar 18, 2026, 21:38 PM -
IMPACT OF EXPEDITED REGULATORY PATHWAYS ON REIMBURSED ACCESS IN EU4,UK,US
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VS HEOR-SPECIFIC GENERATIVE AI IN RARE DISEASE MODELING: A DUCHENNE MUSCULAR DYSTROPHY CASE STUDY
Mar 18, 2026, 21:38 PM -
UPDATING SYSTEMATIC LITERATURE REVIEWS AND REPORTS USING A GENERATIVE AI-ENABLED FRAMEWORK
Mar 18, 2026, 21:38 PM -
STRENGTHENING MATERNAL CARE SYSTEMS IN LOW- AND MIDDLE-INCOME COUNTRIES: MODELING THE ACCESS, HEALTH, AND ECONOMIC IMPACT OF SFLT-1/PLGF TESTING FOR PREECLAMPSIA
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN JAPANESE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS INITIATING EFGARTIGIMOD: A REAL-WORLD RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
CAN A GENERATIVE PATIENT JOURNEY FOUNDATION MODEL ALLEVIATE THE BURDEN OF CANCER SCREENING?
Mar 18, 2026, 21:38 PM -
HOW THE EU JOINT CLINICAL ASSESSMENT UNCERTAINTIES IMPACT US PHARMACEUTICAL MARKET ACCESS
Mar 18, 2026, 21:38 PM
